Effect of STAT3 inhibition on the metabolic switch in a highly STAT3-activated lymphoma cell line.

BACKGROUND Signal transducer and activator of transcription (STAT)3 is involved in a metabolic shift in cancer cells, the Warburg effect through its pro-oncogenic activity. To develop efficient STAT3 inhibitors against cancer cells, novel proteomic and metabolic target molecules need to be explored using multi-omics approaches in the context of STAT3 gene inhibition-mediated tumor growth suppression. MATERIALS AND METHODS We found that short hairpin (sh)RNA-mediated STAT3 inhibition suppressed tumor growth in a highly STAT3-activated lymphoma cell line, SCC-3 cells, and we investigated the effect of STAT3 inhibition on metabolic switching using 2-dimensional differential gel electrophoresis and capillary electrophoresis-time of flight-mass spectrometry. RESULTS We identified latexin as a proteomic marker candidate and metabolic enzymes including fructose-bisphosphate aldolase A (ALDOA) as a metabolic marker candidate for STAT3-targeting therapy using STAT3-specific shRNA gene transduction. In particular, latexin expression was up-regulated in four STAT3-activated cancer cell lines including SCC-3 transduced with STAT3-specific shRNA. The up-regulation of latexin was identified in SCC-3 tumors transplanted to nude mice after treatment with STAT3 inhibitor. CONCLUSION Our results suggest that STAT3 inactivation reverses the glycolytic shift by down-regulating key enzymes and that it induces up-regulation of latexin as a tumor-suppressor molecule, which partially results in cancer cell apoptosis and tumor growth suppression.

[1]  A. Hao,et al.  GRIM-19 opposes reprogramming of glioblastoma cell metabolism via HIF1α destabilization. , 2013, Carcinogenesis.

[2]  K. Storey,et al.  Characterization of Fructose-1,6-Bisphosphate Aldolase during Anoxia in the Tolerant Turtle, Trachemys scripta elegans: An Assessment of Enzyme Activity, Expression and Structure , 2013, PloS one.

[3]  D. Kim,et al.  Inhibition of 15-Hydroxyprostaglandin Dehydrogenase by Helicobacter pylori in Human Gastric Carcinogenesis , 2013, Cancer Prevention Research.

[4]  K. Yamaguchi,et al.  Impact of 2-deoxy-D-glucose on the target metabolome profile of a human endometrial cancer cell line. , 2013, Biomedical research.

[5]  J. Mehta,et al.  Latexin Is Down-Regulated in Hematopoietic Malignancies and Restoration of Expression Inhibits Lymphoma Growth , 2012, PloS one.

[6]  H. Juan,et al.  Ectopic ATP synthase blockade suppresses lung adenocarcinoma growth by activating the unfolded protein response. , 2012, Cancer research.

[7]  Ya-zhuo Zhang,et al.  Loss of 15-hydroxyprostaglandin dehydrogenase indicates a tumor suppressor role in pituitary adenomas. , 2012, Oncology reports.

[8]  J. Swinnen,et al.  ATP-citrate lyase: a key player in cancer metabolism. , 2012, Cancer research.

[9]  T. Ashizawa,et al.  Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay , 2012, Cancer Immunology, Immunotherapy.

[10]  Y. Harada,et al.  Pyrvinium pamoate inhibits proliferation of myeloma/erythroleukemia cells by suppressing mitochondrial respiratory complex I and STAT3. , 2012, Cancer letters.

[11]  Yong Li,et al.  A novel miR‐155/miR‐143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells , 2012, The EMBO journal.

[12]  H. Qiu,et al.  Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation , 2012, Acta Pharmacologica Sinica.

[13]  P. Ward,et al.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.

[14]  Y. Furukawa,et al.  Latexin regulates the abundance of multiple cellular proteins in hematopoietic stem cells , 2012, Journal of cellular physiology.

[15]  Zhuan Zhou,et al.  ATP synthase ecto-α-subunit: a novel therapeutic target for breast cancer , 2011, Journal of Translational Medicine.

[16]  S. Marie,et al.  Metabolism and Brain Cancer , 2011, Clinics.

[17]  T. Ashizawa,et al.  Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation. , 2011, International journal of oncology.

[18]  Y. Ke,et al.  Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential , 2011, BMC Cancer.

[19]  J. Darnell.  STAT3, HIF-1, glucose addiction and Warburg effect , 2010, Aging.

[20]  J. Turkson,et al.  A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction , 2010, Aging.

[21]  A. Balmain,et al.  Guidelines for the welfare and use of animals in cancer research , 2010, British Journal of Cancer.

[22]  D. Geschwind,et al.  Disruption of Astrocyte STAT3 Signaling Decreases Mitochondrial Function and Increases Oxidative Stress In Vitro , 2010, PloS one.

[23]  Chi V Dang,et al.  Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. , 2010, Cancer research.

[24]  M. Tomita,et al.  Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles , 2009, Metabolomics.

[25]  D. Levy,et al.  Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation , 2009, Science.

[26]  Jennifer E. Van Eyk,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2016 .

[27]  P. Fawcett,et al.  Function of Mitochondrial Stat3 in Cellular Respiration , 2009, Science.

[28]  Tsung-Cheng Chang,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.

[29]  Z. Qian,et al.  Identification of ATP synthase beta subunit (ATPB) on the cell surface as a non-small cell lung cancer (NSCLC) associated antigen , 2009, BMC Cancer.

[30]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[31]  F. Liu,et al.  Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis. , 2006, Oncology reports.

[32]  Chi V Dang,et al.  Cancer's molecular sweet tooth and the Warburg effect. , 2006, Cancer research.

[33]  Daniel E Bauer,et al.  ATP citrate lyase inhibition can suppress tumor cell growth. , 2005, Cancer cell.

[34]  Peng Huang,et al.  Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. , 2005, Cancer research.

[35]  J. Darnell,et al.  The role of STATs in transcriptional control and their impact on cellular function , 2000, Oncogene.

[36]  J. Darnell,et al.  Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. , 1994, Science.

[37]  P. Fawcett,et al.  Function of Mitochondrial Stat 3 in Cellular Respiration , 2022 .